English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Five biotransformation products, mefenamic acid-7- O-β-D-glucopyranosyl ester (2), mefenamic acid-7- O-β-D-(β-1,6- O-D-glucopyranosyl)-glucopyranosyl ester (3), mefenamic acid-7- O-β-D-(β-1,2- O-D-glucopyranosyl)-glucopyranosyl ester (4), mefenamic acid-7- O-β-D-(β-1,6- O-D-glucopyranosyl)-2-glucopyranose ester (5), and mefenamic acid-7- O-α-D-(β-1,6- O-D-glucopyranosyl)-2-glucopyranose ester (6) were isolated from cell suspension cultures of Solanum mammosum following administration of the therapeutic agent mefenamic acid (1). The structures of all new compounds were elucidated on the basis of their NMR and mass spectrometric data.

Biotransformation of Mefenamic Acid by Cell Suspension Cultures of Solanum Mammosum